Allergen-specific tolerance induction: Of mice and men

International Archives of Allergy and Immunology

Volumn 166, Issue 2, 2015, Pages 81-83

  Pfützner, Wolfgang ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGIC REACTION; ANTIBODY PRODUCTION; CYTOKINE RELEASE; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SENSITIZATION; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; IMMUNOLOGY; IMMUNOTHERAPY; MOUSE;

ALLERGENS; ANIMALS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; MICE;

EID: 84925432550     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000375406     Document Type: Editorial

References (21)

1. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, Williams H: Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry crosssectional surveys. Lancet 2006; 368: 733-743.
2. Noon L: Prophylactic inoculation against hay fever. Lancet 1911;i:1572-1573.
3. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S: Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007:CD001936.
4. Radulovic S, Calderon MA, Wilson D, Durham S: Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2010:CD002893.
5. Abramson MJ, Puy RM, Weiner JM: Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010:CD001186.
6. Bousquet J, Lockey R, Malling HJ: Allergen immunotherapy: therapeutic vaccines for allergic diseases: a WHO position paper. J Allergy Clin Immunol 1998; 102: 558-562.
7. Akdis M, Akdis CA: Mechanisms of allergenspecific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 2014; 133: 621-631.
8. Matsuoka T, Shamji MH, Durham SR: Allergen immunotherapy and tolerance. Allergol Int 2013; 62: 403-413.
9. Mobs C, Slotosch C, Loffler H, Pfutzner W, Hertl M: Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy. Int Arch Allergy Immunol 2008; 147: 171-178.
10. Renz H: How can animal models lead to improved specific immunotherapy (SIT)? Allergy 1999; 54: 39-40.
11. Tournoy KG, van Hove C, Grooten J, Moerloose K, Brusselle GG, Joos GF: Animal models of allergen-induced tolerance in asthma: are T-reguatory-1 cells (Tr-1) the solution for T-helper-2 cells (Th-2) in asthma? Clin Exp Allergy 2006; 36: 8-20.
12. Kumar RK, Foster PS: Modeling allergic asthma in mice. Am J Respir Cell Mol Biol 2002; 27: 267-272.
13. Fox EM, Torrero MN, Evans H, Mitre E: Immunologic characterization of 3 murine regimens of allergen-specific immunotherapy. J Allergy Clin Immunol 2014, Epub ahead of print.
14. van Rijt LS, Gouveia L, Logiantara A, Canbaz D, Opstelten DJ, van der Kleij HPM, van Ree R: Birch pollen immunotherapy in mice: inhibition of Th2 inflammation is not sufficient to decrease airway hyper-reactivity. Int Arch Allergy Immunol 2014; 165: 128-139.
15. Flicker S, Linhart B, Wild C, Wiedermann U, Valenta R: Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy. Immunobiology 2013; 218: 884-891.
16. Wambre E, DeLong JH, James EA, Torres-Chinn N, Pfutzner W, Mobs C, Durham SR, Till SJ, Robinson D, Kwok WW: Specific immunotherapy modifies allergen-specific CD4 + T-cell responses in an epitope-dependent manner. J Allergy Clin Immunol 2014; 133: 872-9.e7.
17. Mobs C, Ipsen H, Mayer L, Slotosch C, Petersen A, Wurtzen PA, Hertl M, Pfutzner W: Birch pollen immunotherapy results in longterm loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies. J Allergy Clin Immunol 2012; 130: 1108-1116.
18. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C: Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007; 120: 707-713.
19. Mobs C, Slotosch C, Loffler H, Jakob T, Hertl M, Pfutzner W: Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation. J Immunol 2010; 184: 2194-2203.
20. Muller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, Blaser K: Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998; 101: 747-754.
21. Linhart B, Narayanan M, Focke-Tejkl M, Wrba F, Vrtala S, Valenta R: Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy. Clin Exp Allergy 2013; 44: 278-287.